Erin Enright currently serves as a Managing Partner of Prettybrook Partners LLC, a family office dedicated to investing in healthcare companies. She serves as the Chair of the Board, Chair of the Nominating and Governance Committee and member of the Audit Committee and Compensation Committee of Dynatronics Corporation (NASDAQ:DYNT); is a member of the Board of Directors and Chair of Corporate Governance, Nominating and Compensation Committee of Medical Facilities Corporation (TSX:DR); and is a member of the Board and Chair of the Audit Committee of Keystone Dental, Inc., a private company controlled by the private equity firm Accelmed. Previously, she served on the Boards of Directors and chaired the Audit Committees of each of Brooklyn ImmunoTherapeutics, Inc. (NASDAQ:BTX) and Amarin Corporation plc (NASDAQ:AMRN); on the Board of Directors and the Audit Committee of Biolase, Inc. (NASDAQ: BIOL); and was a member of the Board of Directors of Tigerlabs, a Princeton-based business accelerator, and Ceelite Technologies, LLC. She was the President of Lee Medical, a medical device manufacturer based in Plainsboro, New Jersey, from 2004 to 2013. She was Chief Financial Officer of InfuSystem, Inc. (NASDAQ:INFU) from 2005 to 2007. From 1993 to 2003, Ms. Enright was with Citigroup, most recently as a Managing Director in its Equity Capital Markets group. Prior to Citigroup, Ms. Enright was an attorney with Wachtell, Lipton, Rosen & Katz. Ms. Enright received her A.B. from the Woodrow Wilson School of Public and International Affairs at Princeton University and J.D. from the University of Chicago Law School.